Core Biogenesis Market Research Report

Company Overview

Core Biogenesis was founded in 2020 and is headquartered in Paris, France. The company is a pioneering entity in the biotechnology sector, focusing on the production of next-generation recombinant proteins using plant biotechnology. Their primary objective is to significantly reduce production costs using proprietary gene-editing technologies to develop high-value molecules. This innovative platform, which is plant-based, primarily supplies growth factors and cytokines vital for the life sciences and skincare industries.

Product and Industry Focus

Core Biogenesis is distinguished by its advanced expression platforms allowing for species-specific molecule production, including human, bovine, and fish growth factors. The company has a strong focus on the skincare industry, where it has created sophisticated growth factors like EGF and FGF-2. These products are lauded for their stability and effectiveness in combating signs of aging. Key products include Peauvita and Peauforia, which are extensively used in the cosmetics sector.

Financial Milestones

The company has made significant financial strides, having secured $10.5 million in a Series A funding round. Core Biogenesis's total raised capital stands at approximately $13.64 million over three funding rounds. The enterprise's current valuation is estimated to be between $44 to $66 million. This influx of funds is crucial for the development of an industrial-scale facility intended to boost plant-based bioproduction.

Leadership

• Alexandre Reeber: Co-Founder and CEO. Alexander's leadership has been instrumental in positioning Core Biogenesis at the forefront of biotechnology, driving its rapid growth and innovation.

• Chouaib Meziadi: Co-Founder, CSO, and CTO. Chouaib's expertise in plant genetics and bioproduction has been vital in advancing Core Biogenesis's sustainable bioproduction model.

• Clemence Bellanger: Head of Operations. With her previous experience at Entrepreneur First, she brings operational stability and strategic management to the company.

• Daniel Cermeno: Head of Product and Marketing. He centers his focus on solutions for stem cell researchers, ensuring product alignment with industry needs.

• Maurice Moloney: Co-Founder and Advisor, offering extensive expertise to further fortify the company's innovative approaches.

Strategic Partnerships

In 2024, Core Biogenesis formed a strategic partnership with Nucleus Biologics. This collaboration is dedicated to the advancement of manufacturing and distribution channels for cost-effective and sustainable recombinant proteins, strengthening Core Biogenesis's market influence.

Market Presence and Potential

Positioned as a leader within the biotechnology and pharmaceutical industries, Core Biogenesis offers a scalable bioproduction platform that facilitates cost savings and innovation in molecular production. Their plant biofactories not only promise economic benefits but also emphasize sustainable production practices, appealing to environmentally conscious sectors within pharmaceuticals and cosmetics.

Competitor Landscape

Core Biogenesis competes with various entities in the biotechnology and recombinant protein sectors, notable competitors include:

• Qkine: Manufacturer of high-quality growth factors and cytokines for stem cell, organoid, and regenerative medicine markets.

• Future Fields: Innovates in sustainable recombinant protein production, particularly using fruit flies (Drosophila melanogaster) for scaling protein production.

• Protera: Employs Natural Intelligence™ technology in developing functional ingredients for the food industry, enhanced by predictive algorithms.

• Algenex: Specializes in boosting protein production using Baculovirus vector expression systems in insect cells, focusing on both animal and human health sectors.

Notable Mentions

• BioBetter: Engaged in the cultivated meat sector, developing complex protein manufacturing processes aligned with bioproduction.

• Univercells Technologies: Belgian-based company offering corporate-backed solutions in the bioproduction landscape.

For more information, visit their [official website](https://www.corebiogenesis.com).